PROMETRIKA to Present at Medidata NEXT NYC 2018
Published: Oct 10, 2018
Experts from the Cambridge, MA, CRO join industry leaders to discuss the digital transformation of life sciences
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- PPROMETRIKA, LLC (www.prometrika.com), a full-service Clinical Research Organization, announced Heather Paden, Head of Clinical Operations, and Amanda Rychel, Senior Project Manager, will present at Medidata NEXT NYC , October 24 and 25. This event offers keynote speakers, breakout sessions, and interactive learning opportunities for life science industry leaders around the globe. Medidata NEXT NYC is the centerpiece of the largest annual event series of its kind, attracting over 3,000 attendees across events in Basel, Berlin, London, New York, Seoul, Shanghai, and Tokyo.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181010005982/en/
“I am pleased that two of PROMETRIKA’s team members were selected by Medidata to share their expertise with Medidata’s innovative solutions, which are making a difference in driving clinical efficiency and improving research,” said Miganush Stepanians, PhD, President and CEO of PROMETRIKA. “PROMETRIKA is a Medidata Rave EDC Partner and a returning sponsor of Medidata NEXT NYC. We are eager to engage in compelling discussions of best practices in technology solutions with our colleagues in the industry.”
The presentations by PROMETRIKA’s team members include:
The Era of Flexible Monitoring: Centralized Data Review and TSDV
Heather Paden, Head of Clinical Operations
Since June of 2017, EMA has required sponsors to implement the ICH’s expanded acceptable methods for trial monitoring (ICH E6 [R2]). Heather will outline the methods of central monitoring and discuss how these are particularly suited to the study of rare diseases.
Why Rave EDC?
Amanda Rychel, PhD, Sr. Project Manager
Amanda will discuss how Rave EDC’s features and updates have improved EDC management for data managers. With Rave EDC, PROMETRIKA has seen faster User Acceptance Testing (UAT) and efficiencies in account management.
“We’re excited to welcome PROMETRIKA back to Medidata NEXT in New York city, the premier conference to discuss the digital transformation of life sciences,” said Simon Mouyal, Chief Marketing Officer, Medidata. “PROMETRIKA and Medidata share a strong partnership, and we’re looking forward to their sessions on the efficient planning, execution, and reporting of clinical studies.”
Jillian Pammett, 617-844-0240
Source: PROMETRIKA, LLC